vs
Innventure, Inc.（INV）与Arcadia Biosciences, Inc.（RKDA）财务数据对比。点击上方公司名可切换其他公司
Arcadia Biosciences, Inc.的季度营收约是Innventure, Inc.的1.1倍（$901.0K vs $822.0K），Arcadia Biosciences, Inc.净利率更高（-148.3% vs -4593.8%，领先4445.5%）
Innventure, Inc.是一家商业开发与技术商业化企业，与全球大型企业合作，将后者未充分利用的知识产权和研发成果转化为可规模化的高增长独立业务，覆盖可持续发展、先进材料、生命科学等领域，主要服务北美及欧洲市场。
阿卡迪亚生物科学是一家美国上市农业生物技术企业，总部位于加利福尼亚州戴维斯，专注于开发可提升作物品质与产量的作物性状改良技术，该公司部分股权归道德指南针公司所有。
INV vs RKDA — 直观对比
营收规模更大
RKDA
是对方的1.1倍
$822.0K
净利率更高
RKDA
高出4445.5%
-4593.8%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $822.0K | $901.0K |
| 净利润 | $-37.8M | $-1.3M |
| 毛利率 | -1315.8% | 21.4% |
| 营业利润率 | -3859.1% | -152.8% |
| 净利率 | -4593.8% | -148.3% |
| 营收同比 | — | -25.8% |
| 净利润同比 | — | 67.1% |
| 每股收益（稀释后） | $-0.18 | $-0.97 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收INVRKDA
| Q4 25 | $822.0K | $901.0K | ||
| Q3 25 | $534.0K | $1.3M | ||
| Q2 25 | $476.0K | $1.5M | ||
| Q1 25 | $224.0K | $1.2M | ||
| Q4 24 | — | $1.2M | ||
| Q3 24 | $317.0K | $1.5M | ||
| Q2 24 | — | $1.3M | ||
| Q1 24 | — | $987.0K |
净利润INVRKDA
| Q4 25 | $-37.8M | $-1.3M | ||
| Q3 25 | $-28.3M | $856.0K | ||
| Q2 25 | $-84.2M | $-4.5M | ||
| Q1 25 | $-143.0M | $2.6M | ||
| Q4 24 | — | $-4.1M | ||
| Q3 24 | $-2.2M | $-1.6M | ||
| Q2 24 | — | $1.1M | ||
| Q1 24 | — | $-2.4M |
毛利率INVRKDA
| Q4 25 | -1315.8% | 21.4% | ||
| Q3 25 | -676.6% | 32.1% | ||
| Q2 25 | -501.1% | 43.4% | ||
| Q1 25 | 17.9% | 43.2% | ||
| Q4 24 | — | 31.9% | ||
| Q3 24 | -145.1% | 32.9% | ||
| Q2 24 | — | 51.5% | ||
| Q1 24 | — | 52.3% |
营业利润率INVRKDA
| Q4 25 | -3859.1% | -152.8% | ||
| Q3 25 | -5469.1% | -88.5% | ||
| Q2 25 | -29952.5% | -34.4% | ||
| Q1 25 | -116606.3% | 44.2% | ||
| Q4 24 | — | -187.7% | ||
| Q3 24 | -4313.6% | -114.5% | ||
| Q2 24 | — | — | ||
| Q1 24 | — | -160.9% |
净利率INVRKDA
| Q4 25 | -4593.8% | -148.3% | ||
| Q3 25 | -5305.6% | 65.7% | ||
| Q2 25 | -17694.7% | -306.4% | ||
| Q1 25 | -63837.9% | 216.6% | ||
| Q4 24 | — | -334.5% | ||
| Q3 24 | -697.5% | -104.9% | ||
| Q2 24 | — | 81.2% | ||
| Q1 24 | — | -245.5% |
每股收益（稀释后）INVRKDA
| Q4 25 | $-0.18 | $-0.97 | ||
| Q3 25 | $-0.51 | $0.62 | ||
| Q2 25 | $-1.60 | $-3.26 | ||
| Q1 25 | $-3.10 | $1.90 | ||
| Q4 24 | — | $-2.99 | ||
| Q3 24 | $-0.94 | $-1.18 | ||
| Q2 24 | — | $0.78 | ||
| Q1 24 | — | $-1.78 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $60.4M | $4.6M |
| 总债务越低越好 | $8.3M | — |
| 股东权益账面价值 | $204.2M | $4.1M |
| 总资产 | $599.2M | $6.5M |
| 负债/权益比越低杠杆越低 | 0.04× | — |
8季度趋势，按日历期对齐
现金及短期投资INVRKDA
| Q4 25 | $60.4M | $4.6M | ||
| Q3 25 | $9.1M | $5.9M | ||
| Q2 25 | $7.0M | $4.4M | ||
| Q1 25 | — | $3.2M | ||
| Q4 24 | — | $4.2M | ||
| Q3 24 | — | $6.6M | ||
| Q2 24 | — | $8.1M | ||
| Q1 24 | — | $8.5M |
总债务INVRKDA
| Q4 25 | $8.3M | — | ||
| Q3 25 | $29.5M | — | ||
| Q2 25 | $16.8M | — | ||
| Q1 25 | $12.3M | — | ||
| Q4 24 | — | — | ||
| Q3 24 | $14.9M | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
股东权益INVRKDA
| Q4 25 | $204.2M | $4.1M | ||
| Q3 25 | $190.8M | $5.4M | ||
| Q2 25 | $218.6M | $4.5M | ||
| Q1 25 | $261.5M | $8.9M | ||
| Q4 24 | — | $6.2M | ||
| Q3 24 | $-22.3M | $10.3M | ||
| Q2 24 | — | $11.7M | ||
| Q1 24 | — | $10.6M |
总资产INVRKDA
| Q4 25 | $599.2M | $6.5M | ||
| Q3 25 | $556.5M | $8.6M | ||
| Q2 25 | $556.0M | $7.8M | ||
| Q1 25 | $660.4M | $13.0M | ||
| Q4 24 | — | $13.5M | ||
| Q3 24 | $55.7M | $15.2M | ||
| Q2 24 | — | $17.4M | ||
| Q1 24 | — | $16.0M |
负债/权益比INVRKDA
| Q4 25 | 0.04× | — | ||
| Q3 25 | 0.15× | — | ||
| Q2 25 | 0.08× | — | ||
| Q1 25 | 0.05× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-80.7M | $-861.0K |
| 自由现金流经营现金流 - 资本支出 | $-82.1M | — |
| 自由现金流率自由现金流/营收 | -9987.8% | — |
| 资本支出强度资本支出/营收 | 172.4% | 0.0% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $-139.8M | — |
8季度趋势，按日历期对齐
经营现金流INVRKDA
| Q4 25 | $-80.7M | $-861.0K | ||
| Q3 25 | $-19.6M | $-257.0K | ||
| Q2 25 | $-22.1M | $-2.0M | ||
| Q1 25 | $-14.7M | $-1.6M | ||
| Q4 24 | — | $-2.2M | ||
| Q3 24 | — | $-1.8M | ||
| Q2 24 | — | $-2.5M | ||
| Q1 24 | — | $-3.2M |
自由现金流INVRKDA
| Q4 25 | $-82.1M | — | ||
| Q3 25 | $-20.0M | — | ||
| Q2 25 | $-22.1M | — | ||
| Q1 25 | $-15.6M | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | $-2.5M | ||
| Q1 24 | — | $-3.2M |
自由现金流率INVRKDA
| Q4 25 | -9987.8% | — | ||
| Q3 25 | -3747.8% | — | ||
| Q2 25 | -4637.2% | — | ||
| Q1 25 | -6970.1% | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | -188.3% | ||
| Q1 24 | — | -326.5% |
资本支出强度INVRKDA
| Q4 25 | 172.4% | 0.0% | ||
| Q3 25 | 82.2% | 0.0% | ||
| Q2 25 | 3.2% | 0.0% | ||
| Q1 25 | 409.4% | 0.0% | ||
| Q4 24 | — | 0.0% | ||
| Q3 24 | — | 0.0% | ||
| Q2 24 | — | 0.2% | ||
| Q1 24 | — | 1.3% |
现金转化率INVRKDA
| Q4 25 | — | — | ||
| Q3 25 | — | -0.30× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | -0.61× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | -2.31× | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
